Lexicon Pharmaceuticals LXRX Free cash flow
Discontinued — last reported Q4 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's free cash flow?
- Lexicon Pharmaceuticals (LXRX) reported free cash flow of -$17.23M in Q4 2025.
- How has Lexicon Pharmaceuticals's free cash flow changed year-over-year?
- Lexicon Pharmaceuticals's free cash flow increased by 21.5% year-over-year, from -$21.97M to -$17.23M.
- What is the long-term trend for Lexicon Pharmaceuticals's free cash flow?
- Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's free cash flow has grown at a 26.8% compound annual growth rate (CAGR), from -$88.24M to -$179.81M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.